For the quarter ending 2025-09-30, ACXP has $6,105,211 in assets. $2,468,175 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 6,105,211 | - | ||
| Accounts payable and accrued expenses | 2,468,175 | 2,591,527 | ||
| Total current liabilities | 2,468,175 | 2,591,527 | ||
| Total liabilities | 2,468,175 | 2,591,527 | ||
| Common stock .001 par value, 250,000,000 shares authorized, 1,800,299 shares issued and outstanding at september 30, 2025 and 200,000,000 shares authorized, 851,534 shares issued and outstanding at december 31, 2024 | 1,800 | 1,470 | ||
| Additional paid-in capital | 77,345,454 | 75,282,289 | ||
| Accumulated deficit | -73,710,218 | -71,717,428 | ||
| Total shareholders' equity | 3,637,036 | 3,566,331 | ||
| Total liabilities and shareholders' equity | 6,105,211 | 6,157,858 | ||
Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. (ACXP)